Plasma fatty acid patterns during pregnancy and child's growth, body composition, and cardiometabolic health: The

Trudy Voortman1, Myrte J Tielemans1, Wendy Stroobant2

  • 1Department of Epidemiology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands; The Generation R Study Group, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.

Insights

Maternal fatty acid patterns during pregnancy influence offspring growth and cardiometabolic health. High n-3 polyunsaturated fatty acid (PUFA) intake is linked to better body composition and lipid profiles in children.

Area of Science:

  • Reproductive Medicine
  • Pediatric Health
  • Nutritional Science

Background:

  • Fetal exposure to fatty acids impacts offspring growth and metabolism.
  • Previous research often focused on individual fatty acids, overlooking their correlated nature and interactions.
  • Understanding combined fatty acid patterns during pregnancy is crucial for assessing long-term health outcomes.

Purpose of the Study:

  • To investigate associations between maternal plasma fatty acid patterns during pregnancy and the growth, body composition, and cardiometabolic health of offspring at age 6.
  • To identify specific fatty acid patterns that may influence child development and health.
  • To explore the role of n-6 PUFA, MUFA and SFA, and n-3 PUFA patterns in offspring outcomes.

Main Methods:

  • A population-based cohort study of 4830 mother-child pairs in the Netherlands.
  • Plasma phospholipid fatty acids were measured around 20 weeks of gestation.
  • Principal component analysis identified three distinct fatty acid patterns: high n-6 PUFA, MUFA and SFA, and high n-3 PUFA.

Main Results:

  • A high n-6 polyunsaturated fatty acid (PUFA) pattern during pregnancy correlated with increased offspring height, BMI, and fat-free mass index (FFMI) at age 6.
  • The monounsaturated and saturated fatty acid (MUFA and SFA) pattern showed no consistent associations with child body composition or cardiometabolic health.
  • A high n-3 PUFA pattern was associated with lower fat mass index (FMI), higher FFMI, improved HDL-cholesterol, and lower triacylglycerol levels in offspring.

Conclusions:

  • Maternal plasma fatty acid patterns during pregnancy significantly impact offspring body composition and cardiometabolic health.
  • A maternal dietary pattern rich in n-3 PUFA is associated with a more favorable body composition and lipid profile in 6-year-old children.
  • These findings highlight the importance of maternal fatty acid intake for long-term child health outcomes.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
388
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
294
Overview of Fatty Acid Metabolism01:28

Overview of Fatty Acid Metabolism

Lipids also are sources of energy that power cellular processes. Like carbohydrates, lipids are composed of carbon, hydrogen, and oxygen, but these atoms are arranged differently. Most lipids are nonpolar and hydrophobic. Major types include fats and oils, waxes, phospholipids, and steroids.
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
37.5K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
446
Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
3.7K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
257